The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Epithelial tumor cells undergo epithelial-to-mesenchymal transition (EMT) to gain metastatic activity. Competing endogenous RNAs (ceRNAs) have binding sites for a common set of microRNAs (miRs) and regulate each other's expression by sponging miRs. Here, we address whether ceRNAs govern metastasis driven by the EMT-activating transcription factor ZEB1. High miR-181b levels were correlated with an improved prognosis in human lung adenocarcinomas, and metastatic tumor cell lines derived from a murine lung adenocarcinoma model in which metastasis is ZEB1-driven were enriched in miR-181b targets. ZEB1 relieved a strong basal repression of α1 integrin (ITGA1) mRNA, which in turn upregulated adenylyl cyclase 9 mRNA (ADCY9) by sponging miR181b. Ectopic expression of the ITGA1 3'-untranslated region reversed miR-181b-mediated metastasis suppression and increased the levels of adenylyl cyclase 9 protein (AC9), which promoted tumor cell migration and metastasis. In human lung adenocarcinomas, ITGA1 and ADCY9 levels were positively correlated, and an AC9-activated transcriptomic signature had poor-prognostic value. Thus, ZEB1 initiates a miR-181b-regulated ceRNA network to drive metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910 · cited 2×
“In many cases, the biological effects that mRNAs exert through their protein coding and noncoding functions are quite distinct and can be either complementary or antagonistic (30).”
DNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Sadana, R., & Dessauer, C. W. (2009) · Neurosignals · doi:10.1159/000166277 · Cited by 361
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
Pattabiraman, D. R., Bierie, B., Kober, K. I., Thiru, P., Krall, J. A., Zill, C., Reinhardt, F., Tam, W. L., & Weinberg, R. A. (2016) · Science · doi:10.1126/science.aad3680 · Cited by 332
cAMP and Epac in the regulation of tissue fibrosis
Insel, P. A., Murray, F., Yokoyama, U., Romano, S., Yun, H., Brown, L., Snead, A., Lu, D., & Aroonsakool, N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01847.x · Cited by 175
Cited by
Liang, H., Yu, T., Han, Y., Jiang, H., Wang, C., You, T., Zhao, X., Shan, H., Yang, R., Yang, L., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0870-5 · Cited by 348
LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury
Wan, P., Su, W., Zhang, Y., Li, Z., Deng, C., Li, J., Jiang, N., Huang, S., Long, E., & Zhuo, Y. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0351-4 · Cited by 290
Wang, X., Lai, Q., He, J., Li, Q., Ding, J., Lan, Z., Gu, C., Yan, Q., Fang, Y., Zhao, X., et al. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.27359 · Cited by 161
Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
Tsubakihara, Y., & Moustakas, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113672 · Cited by 160
PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma
Tan, X., Banerjee, P., Pham, E. A., Rutaganira, F. U. N., Basu, K., Bota-Rabassedas, N., Guo, H.-F., Grzeskowiak, C. L., Liu, X., Yu, J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax3772 · Cited by 70
Self-citation
Metadata
- Authors
- Tan, X., Banerjee, P., Liu, X., Yu, J., Gibbons, D. L., Wu, P., Scott, K. L., Diao, L., Zheng, X., Wang, J., Jalali, A., Suraokar, M., Fujimoto, J., Behrens, C., Liu, X., Liu, C.-G., Creighton, C. J., Wistuba, I. I., & Kurie, J. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-02-26
- Volume
- 128
- Issue
- 4
- Pages
- 1267-1282
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2783055234
- Cited by
- 68
- References
- 7
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. https://app.cochat.ai/papers/10.1172/jci97225
- The paper
- Tan, X., Banerjee, P., Liu, X., Yu, J., Gibbons, D. L., Wu, P., Scott, K. L., Diao, L., Zheng, X., Wang, J., Jalali, A., Suraokar, M., Fujimoto, J., Behrens, C., Liu, X., Liu, C.-G., Creighton, C. J., Wistuba, I. I., & Kurie, J. M. (2018). The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. Journal of Clinical Investigation. https://doi.org/10.1172/jci97225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.